BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 8113688)

  • 1. The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein.
    Scala G; Ruocco MR; Ambrosino C; Mallardo M; Giordano V; Baldassarre F; Dragonetti E; Quinto I; Venuta S
    J Exp Med; 1994 Mar; 179(3):961-71. PubMed ID: 8113688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 Tat induces the expression of the interleukin-6 (IL6) gene by binding to the IL6 leader RNA and by interacting with CAAT enhancer-binding protein beta (NF-IL6) transcription factors.
    Ambrosino C; Ruocco MR; Chen X; Mallardo M; Baudi F; Trematerra S; Quinto I; Venuta S; Scala G
    J Biol Chem; 1997 Jun; 272(23):14883-92. PubMed ID: 9169458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
    Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
    J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
    Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
    Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 Tat protein can transactivate a heterologous TATAA element independent of viral promoter sequences and the trans-activation response element.
    Roebuck KA; Rabbi MF; Kagnoff MF
    AIDS; 1997 Feb; 11(2):139-46. PubMed ID: 9030359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of responsiveness of a nuclear factor-kappaB-regulated promoter to transactivation by human immunodeficiency virus 1 Tat in HeLa cells.
    Kelly GD; Morris CB; Offermann MK
    Virology; 1999 Oct; 263(1):128-38. PubMed ID: 10544088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in tumor angiogenesis associated with stable expression of the HIV tat gene.
    Huber BE; Richards CA; Martin JL; Wirth PJ
    Mol Carcinog; 1992; 5(4):293-300. PubMed ID: 1379815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B.
    Negrini M; Rimessi P; Sabbioni S; Caputo A; Balboni PG; Gualandri R; Manservigi R; Grossi MP; Barbanti-Brodano G
    Biotechniques; 1991 Mar; 10(3):344-53. PubMed ID: 1829615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
    Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J
    J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines.
    Buonaguro L; Barillari G; Chang HK; Bohan CA; Kao V; Morgan R; Gallo RC; Ensoli B
    J Virol; 1992 Dec; 66(12):7159-67. PubMed ID: 1279199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells.
    Chang LJ; Zhang C
    Virology; 1995 Aug; 211(1):157-69. PubMed ID: 7645208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional regulation of the human interleukin-6 gene promoter in human T-cell leukemia virus type I-infected T-cell lines: evidence for the involvement of NF-kappa B.
    Mori N; Shirakawa F; Shimizu H; Murakami S; Oda S; Yamamoto K; Eto S
    Blood; 1994 Nov; 84(9):2904-11. PubMed ID: 7949164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA transcripts of the human immunodeficiency virus transactivation response element can inhibit action of the viral transactivator.
    Graham GJ; Maio JJ
    Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5817-21. PubMed ID: 1696012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell cycle regulation of human interleukin-8 gene expression by the human immunodeficiency virus type 1 Tat protein.
    Mahieux R; Lambert PF; Agbottah E; Halanski MA; Deng L; Kashanchi F; Brady JN
    J Virol; 2001 Feb; 75(4):1736-43. PubMed ID: 11160671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The HIV-1 transactivator protein Tat is a potent inducer of the human DNA repair enzyme beta-polymerase.
    Srivastava DK; Tendler CL; Milani D; English MA; Licht JD; Wilson SH
    AIDS; 2001 Mar; 15(4):433-40. PubMed ID: 11242139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transactivation of the human interleukin-6 gene by human T-lymphotropic virus type 1 Tax protein.
    Yamashita I; Katamine S; Moriuchi R; Nakamura Y; Miyamoto T; Eguchi K; Nagataki S
    Blood; 1994 Sep; 84(5):1573-8. PubMed ID: 8068947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An autocrine loop of HIV type-1 Tat protein responsible for the improved survival/proliferation capacity of permanently Tat-transfected cells and required for optimal HIV-1 LTR transactivating activity.
    Zauli G; La Placa M; Vignoli M; Re MC; Gibellini D; Furlini G; Milani D; Marchisio M; Mazzoni M; Capitani S
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Nov; 10(3):306-16. PubMed ID: 7552492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transactivation of heterologous promoters by HIV-1 tat.
    Han P; Brown R; Barsoum J
    Nucleic Acids Res; 1991 Dec; 19(25):7225-9. PubMed ID: 1662814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a cellular protein that binds to Tat-responsive element of TGF beta-1 promoter in glial cells.
    Thatikunta P; Sawaya BE; Denisova L; Cole C; Yusibova G; Johnson EM; Khalili K; Amini S
    J Cell Biochem; 1997 Dec; 67(4):466-77. PubMed ID: 9383706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency viruses containing heterologous enhancer/promoters are replication competent and exhibit different lymphocyte tropisms.
    Chang LJ; McNulty E; Martin M
    J Virol; 1993 Feb; 67(2):743-52. PubMed ID: 8419644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.